Are We Predicting Disease Progress of the Rectal Cancer Patients without Surgery after Neoadjuvant Chemoradiotherapy?
2
조회
0
다운로드
3
인용
0
참고문헌
키워드
초록
Purpose There are patients who do not undergo surgery, regardless of tumor response for neoadjuvant chemoradiotherapy (nCRT) in rectal cancer. However, there have been few reports focused on how oncologic outcomes are worse in these patients. We sought to investigate oncologic outcomes for these non-operated patients with rectal cancer after nCRT. Materials and Methods A total of 1,063 records of patients with rectal cancer who were treated with nCRT from January 2002 to December 2013 were retrospectively reviewed. We categorized patients into the non-operated group (n=77), transanal local excision (TLE) group (n=54), or total mesorectal excision (TME) group (n=932) and compared each group using propensity score matching. Results In the non-operated group, the most common reason for no surgery was patient refusal (n=64). Eleven patients were considered to have achieve clinical complete response (cCR), which was an independent prognostic factor of progression-free survival (p=0.045). In patients with disease progression in the non-operated group, the overall survival did not improved according to salvage treatments (p=0.451). The non-operated group showed worse survivals compared to the TLE or TME group before and after matching (p < 0.001). This finding was also noted in the analysis of survival only in patients with cCR. Conclusion In this study, non-operated patients did not secure oncologic safety regardless of cCR after nCRT. Our results suggest that a non-operative management must be carefully considered even if cCR is achieved.
Abstract
Purpose There are patients who do not undergo surgery, regardless of tumor response for neoadjuvant chemoradiotherapy (nCRT) in rectal cancer. However, there have been few reports focused on how oncologic outcomes are worse in these patients. We sought to investigate oncologic outcomes for these non-operated patients with rectal cancer after nCRT. Materials and Methods A total of 1,063 records of patients with rectal cancer who were treated with nCRT from January 2002 to December 2013 were retrospectively reviewed. We categorized patients into the non-operated group (n=77), transanal local excision (TLE) group (n=54), or total mesorectal excision (TME) group (n=932) and compared each group using propensity score matching. Results In the non-operated group, the most common reason for no surgery was patient refusal (n=64). Eleven patients were considered to have achieve clinical complete response (cCR), which was an independent prognostic factor of progression-free survival (p=0.045). In patients with disease progression in the non-operated group, the overall survival did not improved according to salvage treatments (p=0.451). The non-operated group showed worse survivals compared to the TLE or TME group before and after matching (p < 0.001). This finding was also noted in the analysis of survival only in patients with cCR. Conclusion In this study, non-operated patients did not secure oncologic safety regardless of cCR after nCRT. Our results suggest that a non-operative management must be carefully considered even if cCR is achieved.
참고문헌 (23)
- Fokas E, "Tumor regression grading after preoperative chemoradiotherapy for locally advanced rectal carcinoma revisited: updated results of the CAO", ARO, J Clin Oncol, pp.2014, 32[DOI]
- Arredondo J, "Patterns and management of distant failure in locally advanced rectal cancer: a cohort study", Clin Transl Oncol, 18, pp.909~914 (2016)[DOI]
- Huang MY, "DPYD, TYMS, TYMP, TK1, and TK2 genetic expressions as response markers in locally advanced rectal cancer patients treated with fluoropyrimidine-based chemoradiotherapy", Biomed Res Int, 2013, pp.931028~ (2013)
- Wallin U, "CEA: a predictor for pathologic complete response after neoadjuvant therapy for rectal cancer", Dis Colon Rectum, 56, pp.859~868 (2013)[DOI]
- Lai CL, "Rectal cancer with complete clinical response after neoadjuvant chemoradiotherapy, surgery, or "watch and wait"", Int J Colorectal Dis, 31, pp.413~419 (2016)[DOI]
- Beets GL, "A new paradigm for rectal cancer: Organ preservation: Introducing the International Watch & Wait Database (IWWD)", Eur J Surg Oncol, 41, pp.1562~1564 (2015)[DOI]
- Oh BY, "Metformin enhances the response to radiotherapy in diabetic patients with rectal cancer", J Cancer Res Clin Oncol, 142, pp.1377~1385 (2016)[DOI]
- Hur H, "Can a biomarker-based scoring system predict pathologic complete response after preoperative chemoradiotherapy for rectal cancer?", Dis Colon Rectum, 57, pp.592~601 (2014)[DOI]
- Gollins S, "Neoadjuvant treatment strategies for locally advanced rectal cancer", Clin Oncol (R Coll Radiol), 28, pp.146~151 (2016)[DOI]
- Lee SH, "Chemoradiotherapy followed by surgery in rectal cancer: improved local control using a moderately high pelvic radiation dose", Jpn J Clin Oncol, 38, pp.112~121 (2008)[DOI]
- Yeh CH, "Comparison of treatment results between surgery alone, preoperative short-course radiotherapy, or long-course concurrent chemoradiotherapy in locally advanced rectal cancer", Int J Clin Oncol, 17, pp.482~490 (2012)[DOI]
- Hingorani M, "Avoiding radical surgery after pre-operative chemoradiotherapy: a possible therapeutic option in rectal cancer?", Acta Oncol, 51, pp.275~284 (2012)[DOI]
- Habr-Gama A, "Watch and wait approach following extended neoadjuvant chemoradiation for distal rectal cancer: are we getting closer to anal cancer management", Dis Colon Rectum, 56, pp.1109~1117 (2013)[DOI]
- Smith FM, "Avoiding radical surgery improves early survival in elderly patients with rectal cancer, demonstrating complete clinical response after neoadjuvant therapy: results of a decision-analytic model", Dis Colon Rectum, 58, pp.159~171 (2015)[DOI]
- Habr-Gama A, "Local recurrence after complete clinical response and watch and wait in rectal cancer after neoadjuvant chemoradiation: impact of salvage therapy on local disease control", Int J Radiat Oncol Biol Phys, 88, pp.822~828 (2014)[DOI]
- Renehan AG, "Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysis", Lancet Oncol, 17, pp.174~183 (2016)[DOI]
- Li J, "Wait-and-see or radical surgery for rectal cancer patients with a clinical complete response after neoadjuvant chemoradiotherapy: a cohort study", Oncotarget, 6, pp.42354~42361 (2015)
- Hughes R, "Could a wait and see policy be justified in T3", 4 rectal cancers after chemo-radiotherapy?, 2010, pp.49, 378~381
- dos Santos LV, "Watch and wait policy remains experimental for the management of rectal cancer", Colorectal Dis, 12, pp.833~ (2010)
- Glynne-Jones R, "Critical appraisal of the 'wait and see' approach in rectal cancer for clinical complete responders after chemoradiation", Br J Surg, 99, pp.897~909 (2012)[DOI]
- Yu CS, "Local excision after neoadjuvant chemoradiation therapy in advanced rectal cancer: a national multicenter analysis", Am J Surg, 206, pp.482~487 (2013)[DOI]
- 노재명, "Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06)", Cancer Research and Treatment, 46(3), pp.243~249 (2014), 대한암학회
- 이남권, "Clinical Outcomes of Local Excision Following Preoperative Chemoradiotherapy for Locally Advanced Rectal Cancer", Cancer Research and Treatment, 46(2), pp.158~168 (2014), 대한암학회